Iterum Therapeutics plc (ITRMF) Receivables - Other (2017 - 2022)

Iterum Therapeutics has reported Receivables - Other for 6 years, with the latest figure at $55000.0 in Q4 2022.

• On a quarterly basis, Receivables - Other fell 81.03% year-over-year to $55000.0 in Q4 2022; TTM through Dec 2022 was $55000.0, a 81.03% decrease from a year earlier, with the FY2022 full-year figure at $55000.0, down 81.03% from the prior year.
• Receivables - Other was $55000.0 for Q4 2022 at Iterum Therapeutics, down from $81000.0 in the prior quarter.
• The five-year high for Receivables - Other was $290000.0 in Q4 2021, with the low at $7000.0 in Q4 2019.
• Average Receivables - Other over 5 years is $119125.0, with a median of $111500.0 recorded in 2022.
• The sharpest annual moves came in 2019 and 2021: Receivables - Other slumped 95.57% in 2019, then surged 553.85% in 2021.
• Over 5 years, Receivables - Other stood at $158000.0 in 2018, then plunged by 95.57% to $7000.0 in 2019, then soared by 85.71% to $13000.0 in 2020, then soared by 2130.77% to $290000.0 in 2021, then sank by 81.03% to $55000.0 in 2022.
• The last three Receivables - Other figures came in at $55000.0 (Q4 2022), $81000.0 (Q3 2022), and $123000.0 (Q2 2022), per Business Quant data.